For help on how to get the results you want, see our search tips.
3 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Withdrawn applications Remove Withdrawn applications filter
Medicine type
Accelerated assessment Remove Accelerated assessment filter
Exceptional circumstances Remove Exceptional circumstances filter
Biosimilar Remove Biosimilar filter
Conditional approval Remove Conditional approval filter
Generic Remove Generic filter
Application type
Initial authorisation Remove Initial authorisation filter
-
List item
Summary of opinion: Rybrevant
amivantamab, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Sapropterin Dipharma
sapropterin, opinion date: 16/12/2021, Positive, Last updated: 17/12/2021 -
List item
Summary of opinion: Sitagliptin / Metformin hydrochloride Mylan
metformin hydrochloride, sitagliptin hydrochloride monohydrate, opinion date: 16/12/2021, Positive, Last updated: 17/12/2021